Lower Superoxide Dismutase 2 (SOD2) Protein Content in Mononuclear Cells Is Associated with Better Survival in Patients with Hemodialysis Therapy

Table 1

Population characteristics of subjects for superoxide dismutase 2 protein comparisons. Values are given as median (interquartile range) or number (percent).

		Age; (years)	BMI; (kg/m^2)	Gender; male (%)
Healthy controls	13	46 (41–52)	23.6 (20.6–25.2)	7 (54)
CKD stage 1	32	56 (44–67)	24.6 (22.7–28.5)	23 (72)
CKD stage 2	22	65 (57–70)	27.5 (22.7–32.3)	12 (55)
CKD stage 3	28	71 (62–80)	26.1 (22.0–28.4)	18 (64)
CKD stage 4	29	67 (60–74)	26.7 (22.6–31.0)	22 (76)
CKD stage 5	9	71 (56–75)	26.2 (24.6–30.7)	3 (33)
CKD stage 5 HD	81	66 (57–73)	24.4 (22.2–28.5)	47 (58)

HD = hemodialysis therapy.